Allworth Financial’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.6K Buy
2,551
+15
+0.6% +$453 ﹤0.01% 2041
2026
Q1
$60.4K Buy
2,536
+3
+0.1% +$83 ﹤0.01% 2180
2025
Q4
$70.2K Buy
2,533
+11
+0.4% +$281 ﹤0.01% 1970
2025
Q3
$61.2K Buy
2,522
+9
+0.4% +$179 ﹤0.01% 1982
2025
Q2
$42.7K Buy
2,513
+2,478
+7,080% +$43.2K ﹤0.01% 2045
2025
Q1
$706 Sell
35
-31
-47% -$812 ﹤0.01% 3587
2024
Q4
$1.74K Sell
66
-39
-37% -$995 ﹤0.01% 3199
2024
Q3
$2.57K Hold
105
– – ﹤0.01% 2853
2024
Q2
$2.72K Sell
105
-99
-49% -$2.43K ﹤0.01% 2786
2024
Q1
$6.74K Sell
204
-362
-64% -$11.3K ﹤0.01% 2277
2023
Q4
$15.4K Sell
566
-539
-49% -$13.4K ﹤0.01% 1791
2023
Q3
$26.6K Buy
1,105
+686
+164% +$18.4K ﹤0.01% 1364
2023
Q2
$13.4K Buy
419
+57
+16% +$1.85K ﹤0.01% 1760
2023
Q1
$11.1K Sell
362
-30
-8% -$1.18K ﹤0.01% 1755
2022
Q4
$15.3K Sell
392
-3
-0.8% -$134 ﹤0.01% 1505
2022
Q3
$19K Sell
395
-70
-15% -$3.99K ﹤0.01% 1305
2022
Q2
$18K Hold
465
– – ﹤0.01% 1273
2022
Q1
$27K Buy
465
+63
+16% +$4.13K ﹤0.01% 1121
2021
Q4
$32K Hold
402
– – ﹤0.01% 956
2021
Q3
$35K Hold
402
– – ﹤0.01% 869
2021
Q2
$52K Sell
402
-200
-33% -$15.9K ﹤0.01% 606
2021
Q1
$48K Buy
602
+140
+30% +$13.3K ﹤0.01% 583
2020
Q4
$38K Buy
462
+242
+110% +$11.9K ﹤0.01% 526
2020
Q3
$5K Buy
+220
New +$5.46K ﹤0.01% 832

Other funds holding BEAM

Allworth Financial's BEAM Position: Q2 2026 in Review

Allworth Financial increased its Beam Therapeutics (BEAM) stake by 0.59% in Q2 2026, buying an estimated $453 and bringing the position to 2,551 shares worth $87.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Allworth Financial first reported a position in BEAM in Q3 2020 and has held it in 24 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Allworth Financial held 2,551 shares of Beam Therapeutics worth $87.6K as of Q2 2026.
  • Allworth Financial bought 15 Beam Therapeutics shares in Q2 2026, an estimated $453.
  • Beam Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2041 holding.
  • Allworth Financial first reported a position in Beam Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.